Egyptian Prime Minister Ibrahim Mehleb and Health Minister Adel al-Adawy have signed an agreement with the U.S.’s …
"Gilead"
-
-
FeatureIndustry & TradeTech/AI
Egypt’s Eva Pharma to export 1st batch of coronavirus treatment Favipiravir
by Sanaa Allamby Sanaa AllamEgyptian drug-maker, Eva Pharma, is ready to start exporting “Favipiravir” an anti-viral compound that has proven to …
-
Egypt’s pharmaceutical industry is growing at the fastest pace in nearly two years, Health Minister Hala Zayed …
-
FeatureIndustry & TradeTech/AI
Eva Pharma in talks with international companies to manufacture covid-19 vaccines in Egypt
by Sanaa Allamby Sanaa AllamEgyptian drugmaker Eva Pharma said that it aims to sign number of co-operation protocols with international companies …
-
FeatureIndustry & TradeTech/AI
Eva Pharma doubles antibiotics, blood clotting drugs production to help in treating Covid-19
by Sanaa Allamby Sanaa AllamEgypt-based Eva Pharma, manufacturing and sale of remdesivir, said that the company has doubled the production capacity …
-
Egypt is developing four vaccines that have been registered by the World Health Organisation (WHO) to treat …
-
Gilead Sciences Inc priced its COVID-19 antiviral remdesivir at $2,340 per patient for wealthier nations and agreed …
-
FeatureIndustry & TradeTech/AI
Egypt’s Eva Pharma begins manufacturing of coronavirus drug Avipiravir approved by Russia
by Sanaa Allamby Sanaa AllamEgyptian drugmaker Eva Pharma announced on Monday that it has begun manufacturing antiviral drug Avipiravir, which has …
-
Industry & TradeTech/AI
U.S. awards AstraZeneca $23 million to help develop treatment for coronavirus antibody
The U.S. federal government announced on Tuesday it is awarding drug giant AstraZeneca $23.6 million to help …
-
International NewsNews
Trump is taking hydroxychloroquine to prevent coronavirus infection despite FDA warning
U.S. President Donald Trump, in a surprise announcement, said on Monday he is taking hydroxychloroquine as a …